Latest News From Pharmachem
-
FREE Training for the unemployed
14 January, 2015
Did you know that we also provide free training for jobseekers? Full full details watch our video via the link below.
-
Irish-headquartered clinical trials firm Icon to create 200 jobs
01 February, 2015
Irish-headquartered clinical trials firm Icon to create 200 jobs
-
Four initiatives from across Africa win share of global US$1 million Healthcare Innovation Award
03 February, 2015
Four initiatives from across Africa win share of global US$1 million Healthcare Innovation Award
-
ICON to buy US-based MediMedia Pharma Solutions
03 February, 2015
Irish multinational company ICON has announced a deal to buy US-based MediMedia Pharma Solutions for $120m.
-
Guinea approves Fujifilm's Avigan to treat early Ebola cases
09 February, 2015
INGAPORE--The head of Guinea's Ebola-response program wasted no time announcing approval of Fujifilm's Avigan (favipiravir) influenza drug to treat early cases of Ebola in the West African nation.Program Coordinator Sakoba Keita said the drug, developed by Fujifilm's Toyama Chemical unit, would be available only in three special Ebola-treatment centers in the country and possibly two additional centers later. Using Avigan to treat patients with low to moderate levels of the virus in their blood will be limited to those clinics. The drug would not be made available to patients in hospitals, either public or private, the government said. "It takes training of health workers on the use of this drug," the announcement said. The government acted soon after Toyama disclosed preliminary results from Phase I clinical trials showing the drug trimmed the mortality rate in early stages to 15% from 30%. The patients also reported no adverse side effects from Avigan.
-
Voxpro tie-up with US skincare group creates 43 jobs in Cork
10 February, 2015
Irish multilingual call centre partners with It Works!
-
Government to announce regional strategy on jobs today
11 February, 2015
The Government is announcing its regional strategy under the Action Plan for Jobs this morning.
-
Cost of Soliris drug will impact other areas of health service, says HSE chief
12 February, 2015
The head of the HSE has admitted that the rest of the health service will have to suffer because of a decision to pay for expensive drugs for patients with a rare blood disorder.
-
GSK strengthens early stage vaccine pipeline with acquisition of GlycoVaxyn AG
13 February, 2015
GSK has acquired GlycoVaxyn AG, a specialist vaccine biopharmaceutical company based in Switzerland. Since forming a scientific collaboration in 2012, GSK has held a minority stake in GlycoVaxyn and has now acquired the remaining shares for US $190 million (approximately £124 million) in cash to take full ownership of the company.
-
Short-term use of hormone replacement therapy associated with increased ovarian cancer risk
16 February, 2015
Taking hormone replacement therapy (HRT) for the menopause, even for just a few years, is associated with a significantly increased risk of developing the two most common types of ovarian cancer, according to a detailed re-analysis of all the available evidence, published in The Lancet.
-
New therapeutic principle for Parkinsonian dyskinesia shows clinical effect
17 February, 2015
Involuntary dyskinetic movements induced by treatment with levodopa (L-dopa) are a common problem for people with Parkinson's disease. Now, however, researchers at Karolinska Institutet and Lund University in Sweden seem to be close to a novel therapy to this distressing side effect.
-
Sanofi and Lead Pharma to develop treatments for autoimmune diseases
19 February, 2015
Sanofi announced today that it has entered into a research collaboration and license agreement with Dutch biotech Lead Pharma to discover, develop and commercialize small-molecule therapies directed against the nuclear hormone receptors called ROR gamma t to treat a broad range of autoimmune disorders, including rheumatoid arthritis, psoriasis and inflammatory bowel disease, which are among the most common.
-
New test to predict the effectiveness of cancer vaccines
20 February, 2015
Cancer vaccines are designed to turn the body's own immune system specifically against tumor cells. Particularly promising are vaccines that are directed against so-called neoantigens: These are proteins that have undergone a genetic mutation in tumor cells and, therefore, differ from their counterparts in healthy cells.
-
iManageCancer Survey: Your Opinion Counts
23 February, 2015
Would you like to contribute to the future of cancer treatment in technology? iManageCancer project is trying to find out how mobile healthcare (mHealth) and serious games might help people with chronic illnesses and in particular cancer. Significant improvements due to cancer research have led to more cancer patients being cured, and very many more enabled to live with their condition.
-
Horizon Pharma opens new global headquarters in Dublin
24 February, 2015
Company to create 60 highly-skilled jobs in Dublin over next three years
-
Novartis receives FDA approval of Farydak®, the first HDAC inhibitor for patients with multiple myeloma
25 February, 2015
Novartis announced today that the US Food and Drug Administration (FDA) has approved Farydak® (panobinostat, previously known as LBH589) capsules in combination with bortezomib* and dexamethasone for the treatment of patients with multiple myeloma who have received at least two prior regimens, including bortezomib and an immunomodulatory (IMiD) agent[1]
-
Graphene shows potential as novel anti-cancer therapeutic strategy
26 February, 2015
University of Manchester scientists have used graphene to target and neutralise cancer stem cells while not harming other cells. This new development opens up the possibility of preventing or treating a broad range of cancers, using a non-toxic material. Writing in the journal Oncotarget, the team of researchers led by Professor Michael Lisanti and Dr Aravind Vijayaraghavan has shown that graphene oxide, a modified form of graphene, acts as an anti-cancer agent that selectively targets cancer stem cells (CSCs).
-
Omega-3 fatty acids and vitamin D may control brain serotonin
27 February, 2015
Although essential marine omega-3 fatty acids and vitamin D have been shown to improve cognitive function and behavior in the context of certain brain disorders, the underlying mechanism has been unclear. In a new paper published in FASEB Journal by Rhonda Patrick, PhD and Bruce Ames, PhD of Children's Hospital Oakland Research Institute (CHORI), serotonin is explained as the possible missing link tying together why vitamin D and marine omega-3 fatty acids might ameliorate the symptoms associated with a broad array of brain disorders.
-
Novartis, GSK complete deals to reshape both drugmakers
02 March, 2015
GSK to receive net after tax proceeds of $7.8 bn GlaxoSmithKline and Novartis said on Monday they had completed a series of asset swaps worth more than $20 billion that will reshape both drugmakers.
-
Sun Pharma to buy Glaxo's opiates business in Australia
03 March, 2015
Sun Pharmaceutical Industries Ltd(SUN.NS), India's largest drugmaker by sales, said on Tuesday it has agreed to buy GlaxoSmithKline's(GSK.L) opiates business in Australia to strengthen its pain management portfolio.
-
Sun Pharma to buy Glaxo's opiates business in Australia
03 March, 2015
Sun Pharmaceutical Industries Ltd(SUN.NS), India's largest drugmaker by sales, said on Tuesday it has agreed to buy GlaxoSmithKline's(GSK.L) opiates business in Australia to strengthen its pain management portfolio.
-
Novartis announces completion of transactions with GSK
04 March, 2015
Novartis announced today that it has completed a series of transactions with GlaxoSmithKline plc (GSK), including the acquisition of certain oncology products and pipeline compounds from GSK, the creation of a world-leading consumer healthcare business through a joint venture that combines the two companies' consumer divisions, and the divestiture of the Novartis non-influenza Vaccines business to GSK.
-
AbbVie boosts cancer drug pipeline with Pharmacyclics deal
05 March, 2015
AbbVie is to buy Pharmacyclics for about $21 billion, giving it access to what is expected to be one of the world’s top-selling cancer drugs and expanding its reach in the profitable oncology field.
-
Novartis leads way in pharma productivity
09 March, 2015
Swiss group pushes through sweeping reorganisation aimed at boosting growth
-
Novartis leads way in pharma productivity
09 March, 2015
Swiss group pushes through sweeping reorganisation aimed at boosting growth
-
Training skills for SME’s (Subject Matter Experts)
10 March, 2015
We are looking for a panel of trainers in Training skills for SME’s (Subject Matter Experts)specific to the pharmaceutical industry, if you are interested please give a 1 page quote on headed paper to info@pharmachemskillnet.ie
-
Pfizer Little Island
10 March, 2015
We are delighted to hear our member company is safe from redundancy and will keep manufacturing in Little Island.
-
Mayo Clinic and collaborators find new class of drugs that reduces aging in mice
11 March, 2015
A new class of drugs identified and validated by Mayo Clinic researchers along with collaborators at Scripps Research Institute and others, clearly reduces health problems in mice by limiting the effect of senescent cells - cells that contribute to frailty and diseases associated with age. The researchers say this is a first step toward developing similar treatments for aging patients. Their findings appear today in the journal Aging Cell.
-
GlaxoSmithKline sells half its stake in Aspen Pharmacare
13 March, 2015
Drugmaker is reorganising amid a slump in sales, as Advair faces increases competition
-
Salix accepts takeover offer from Valeant
16 March, 2015
Pharma group accepts higher bid as Dublin based bidder Endo withdraws
-
GSK becomes partner in new global fund to accelerate dementia research
18 March, 2015
GSK today announced it will be a key partner, with an investment of $25m (approx £17m), in a pioneering new global fund for dementia research. The Dementia Discovery Fund, which is being established by the UK government with initial commitments totaling $100m, brings together leading pharmaceutical companies, the UK government and Alzheimer's Research UK to address the rising threat posed by dementia by supporting research into future treatments.
-
SPECIAL REPORT: The anti-depressant generation
19 March, 2015
We have always sought ways of coping with depression and anxiety, but our reliance on drugs and the regional variations make for alarming reading, writes Catherine Shanahan.
-
Ireland’s Malin raises €330m in initial public offering
20 March, 2015
Malin has raised €330 million in one of Europe’s biggest biotechnology IPOs, a source close to the life sciences company has said, surpassing its target range of €275 million to €325 million.
-
Excel Introduction
23 March, 2015
Take the first steps with our 1 day Excel Introduction course for novices. course is taking place in the SilverSprings Hotel on the 1st April. http://www.pharmachemskillnet.ie/index.cfm?page=viewEvent&id=541
-
Pfizer, Lilly to resume study testing pain drug after FDA lifts hold
24 March, 2015
Pfizer expects to receive $200m upfront payment from Lilly as a result of development
-
Conatus Pharma's liver drug succeeds in mid-stage study, shares soar
26 March, 2015
(Reuters) - Conatus Pharmaceuticals Inc said its experimental lead drug was more effective than a placebo in a mid-stage study in patients with a form of fatty liver disease.
-
Outsourcing firm OSC announces 70 new Dublin jobs
27 March, 2015
Irish-owned, specialist outsourcing firm Outsource Services Group OSC have announced 70 new jobs at their Dublin offices.
-
Good news on Cork's Jobs Front
30 March, 2015
Lucky Stryker to create hundreds of jobs in Cork One of the world’s leading medical technology companies is expected to announce the creation of hundreds of jobs with a multi-million euro investment in a new global centre of excellence in Co Cork.
-
How to Audit – Sterile Products Manufacture
30 March, 2015
Pharmachem Skillnet are Looking for training providers who can deliver the How to Audit – Sterile Products Manufacture programme, please contact info@pharmachemskillnet.ie for Template.
-
Novartis accelerates cancer immunotherapy efforts with Aduro Biotech alliance and launch of new immuno-oncology research group
31 March, 2015
Novartis announced today that it is stepping up its efforts to harness the body's immune system to combat cancer. The company has entered into a major multiyear alliance with Aduro Biotech that is focused on the discovery and development of next generation cancer immunotherapies targeting the STING (Stimulator of Interferon Genes) pathway and launched a new immuno-oncology research group led by renowned cancer vaccine expert Glenn Dranoff, MD.
-
Researchers question use of paracetamol for lower back pain and osteoarthritis
02 April, 2015
New research shows that paracetamol is ineffective in reducing pain, disability or improving quality of life for patients who suffer from low back pain or osteoarthritis of the hip or knee, and its use may affect the liver. The study published in the British Medical Journal provides new evidence that paracetamol is no better at treating low back pain than a placebo and its effect on osteoarthritis of the hip or knee is too small to be clinically worthwhile
-
Bayer Grants4Apps® Accelerator: Submissions Open for Digital Health Startups
07 April, 2015
The Grants4Apps® Accelerator is a mentoring program for digital health startups taking place in Berlin. This year's batch with five startups runs from August 10th until December 4th, 2015. The program offers mentoring by entrepreneurs and Bayer experts, office space for 100 days at Bayer HealthCare Pharmaceuticals headquarters, and funding of 50,000€.
-
Data Integrity Presentation with David Twohig
10 April, 2015
Industry only event - Data Integrity Presentation 22nd April in Radisson SAS Little Island 8am -11am
-
Irish Econmy to grow 5.4% this year, says Ibec
13 April, 2015
The Irish economy will continue to outperform the rest of Europe and grow by 5.4 per cent this year, Ibec has said.
-
Profits jump 56pc at chemical firm to €1.1m
20 April, 2015
Pre-tax profits at the firm employed by the Government to deliver the material used for the contentious fluoridation of the State's water supply last year jumped by 56pc to €1.16m.
-
Mayo and New York in $300m fibre optic cable link
21 April, 2015
A $300m fibre optics cable between New York and Mayo is set to go ahead after the promoters secured a multimillion euro loan and planning permission
-
Dairy firm Ornua to grow via acquisition and sales
22 April, 2015
Further acquisitions, partnerships, and placing marketing personnel in target markets will be central to Ornua’s global sales growth plans.
-
Roche reports strong sales growth in the first quarter of 2015
24 April, 2015
The Roche Group posted strong sales growth in the first three months in both divisions, with demand for oncology and immunology medicines driving growth in Pharmaceuticals, and immunodiagnostics products driving growth in Diagnostics.
-
Mylan shares soar after takeover proposal
27 April, 2015
It’s been a busy few weeks for US pharma giant Mylan, which reports quarterly earnings today. Firstly, it made a proposal to buy Dublin-based Perrigo, in a deal valued at approximately $29 billion.
-
Training provider required - Level 6 Cert in Training and Development
20 May, 2015
PharmaChem Skillnet are currently sourcing training providers to run a Level 6 Certificate course in Training and Development. We are hoping to roll out this programme over the next few weeks. If this falls under your remit please contact Susan ASAP on 021 4822002 or 087 2876731
-
Government launches €5m centre for connected health technology
20 May, 2015
A €5m government backed centre, which will develop new connected technology for use in the healthcare sector was officially launched on May 18th.
-
New Cystic Fibrosis drug developed by Scientists at Queens University
20 May, 2015
A new drug treatment could improve the lives of children born with the genetic condition cystic fibrosis, and may even allow them to live longer, say researchers involved in a groundbreaking trial.
-
Dublin based pharmaceutical company Mallinckrodt to create 45 jobs
20 May, 2015
Dublin based pharmaceuticals company Mallinckrodt is to create 45 highly-skilled jobs as part of a €45 million investment. The company is to establish a new manufacturing facility at the College of Business and Technology Park in Blanchardstown, Dublin 15. The development will provide 300 jobs during the construction phase and 45 skilled positions once the facility is completed.
-
Venn Life Sciences reports revenue of €4.9m
25 May, 2015
Clinical research group Venn Life Sciences has reported revenue of €4.9 million for 2014, up 140% on the €2.04 million announced in 2013.
-
Novartis working on "robotic pill" to deliver biotech drugs
27 May, 2015
Swiss drugmaker Novartis is collaborating with US start-up Rani Therapeutics on a “robotic pill” for complex biotech drugs that would normally have to be given by injection.
-
Analysts predict Finance Minister Michael Noonan could have €2.5bn to spend in budget
04 June, 2015
Finance Minister Michael Noonan could have €2.5bn to spend in pre-election budget giveaways because the economy is growing so rapidly, analysts say. The predictions come as the Department of Finance released another set of buoyant exchequer figures. These showed that the Government collected overall tax revenues of over €17.28bn in the first five months to the end of May, up 10.9% in the year. Vat receipts rose by 9.5% to €5.7bn, income tax receipts increased by 6.7% to over €7.03bn, while excise taxes rose to over €2bn, a 4.5% rise in the year. The Department of Finance said in its Spring Economic Statement in April that it could have room to spend €1.2bn in an expansionary budget package that was evenly split between tax cuts and spending increases. However, analysts say that the Coalition could now secure a budget bounty of €2.5bn. “We are opening up scope because of momentum in the economy. Tax-rich elements such as cars and houses are doing relatively well, so consumer demand should deliver a budget largesse over the year,” said Austin Hughes, chief economist at KBC Bank Ireland. “I’d be very much surprised if the budget leeway wasn’t well above €2bn and the link between taxes and GDP points to as much as €2.5bn,” Mr Hughes said. Alan McQuaid, chief economist at Merrion Capital, predicted that the Coalition would present a budget in October that offered a package well over the €1.2bn in tax cuts and spending increases projected by the Department of Finance. “My worry is that there are signs on public spending that we are going back to the bad old days. The opinion polls may dictate how big the budget spending package will be. I do not think we have learned from past mistakes,” he said. Alan Ahearne, professor and head of economics at NUI Galway, said the growth in tax receipts appears to give the Government scope for a budget package of over €1.5bn, but it will nonetheless be constrained by the EU’s strict budget rules. “They have a choice to get the deficit down faster or have a looser budget, but whatever they do they have to agree it with the Commission. The Commission will have as much a say on the windfall the Government will have and on how much should be squirreled away to lower the deficit,” Prof Ahearne said. Analysts say economic data in recent weeks show that the economy is expanding rapidly. The latest Quarterly National Household Survey from the CSO showed employment grew by 2.2% in the first three months of the year. The CSO’s latest unemployment bulletin yesterday recorded a jobless rate of 9.8% in May, down from 11.7% from the corresponding month last year and well below the peak of 15.1% recorded in early 2012. New data earlier this week also showed that manufacturing output in May grew at its fastest rate in three months, marking two straight years of uninterrupted growth. Retail sales figures for April showed sales grew at their fastest rate for more than 14 years, though some commentators remain concerned debt-ridden consumers may still hold back.
-
Irish based Shire said to be considering a $18bn takeover of Actelion to boost rare diseases business
08 June, 2015
Shares in Actelion, Europe’s biggest biotech company, jumped 7 per cent to a record high on Monday after a report Shire was considering a $18 billion takeover
-
Irish based life science company Malin to invest $35 in Melinta Therapeutics
10 June, 2015
Malin, an Irish-based company set up by a number of former Elan executives to invest in privately held life science assets, has invested $35 million and committed to invest a further $10 million in Melinta Therapeutics. The announcement marks Malin’s first new asset following its stock exchange debut earlier this year and brings the number of operating assets within the group to eight. Melinta Therapeutics is a private company developing novel antibiotics to treat bacterial infections. Malin has joined founding investors, Vatera Healthcare Partners, and other existing investors in a Series 4 funding round of up to $67 million.
-
CSO Figures show large increase in output from Irish factories in April
11 June, 2015
The run of positive indicators for the economy has continued, with official figures published yesterday showing another large increase in output from Irish factories in April. The CSO said that production rose in the month by 1.7% from March and was 9.7% higher from April 2014. That 9.7% annual increase was lower than the huge increases of over 27% and almost 37% posted in March and February, but nonetheless showed that manufacturing output was expanding at a fair clip, analysts said.
-
Bayer to sell diabetes devices unit to Panasonic for €1bn
12 June, 2015
Bayer is to sell its diabetes devices unit to Panasonic Healthcare , a joint venture backed by buyout firm KKR, for about €1 billion. The unit makes blood-glucose monitoring systems and other devices used by some of the 350 million people who live with diabetes, Leverkusen, Germany-based Bayer and Tokyo-based Panasonic Healthcare said in a statement on Wednesday.
-
Surge in Pharma exports sees the value of Ireland's export trade climb to an all time high
15 June, 2015
A surge in pharma exports saw the value of Ireland’s export trade climb an all-time high in April. Provisional figures from the Central Satistics Office (CSO) show seasonally adjusted exports for April rose by €989 million (12 per cent) to €9.3 billion. This represented the highest monthly figure in the history of the series and underscores the strength of Ireland’s current economic recovery.
-
Johnson & Johnson Vision Care to invest €100m in expansion of its Limerick facility
16 June, 2015
Johnson & Johnson which trades as Vistakon Ireland in Limerick is to invest €100m in expanding its facility in the National Technology Park, Plassey Limerick.
-
Galway based Neuvari raise €19m equity capital to fund clinical trial for stroke treatment device
18 June, 2015
Galway-based medical-device company Neuravi is to start a multi-million euro clinical trial on a stroke treatment device later this year after raising €19m in capital.
-
Eurozone Business Growth at four year high
23 June, 2015
Euro zone private businesses expanded at their fastest pace in four years this month, a survey showed today, providing the clearest signs yet of a solid recovery in the region.
-
Cork based medical diagnostics company secures €4.5m investment from the European Commission
24 June, 2015
Radisens Diagnostics, based at CIT’s Rubicon Centre, landed the grant from the commission’s Horizon 2020 Research and Innovation initiative to help develop a blood testing device that will provide instant diagnosis for chronic diseases.
-
Recovering construction sector seeking return of Irish emigrants
26 June, 2015
Recruiters are seeking to persuade skilled Irish emigrants in Australia, New Zealand and Canada to return home to pursue job opportunities in the recovering construction sector.
-
AbbVie announces €40 million investment in Sligo
29 June, 2015
AbbVie is to expand its medical device manufacturing facility in Sligo, creating 50 highly-skilled jobs over the next four years.
-
Consumer confidence hits nine year high
30 June, 2015
The prospect of tax cuts and public spending increases in the next Budget and the announcement of public sector pay rises have buoyed sentiment among householders.
-
Private healthcare company investor Malin purchases a 38% shareholding in Irish based 3D4Medical
01 July, 2015
Based in Ireland 3D4Medical specialises in the development of medical, educational, health and fitness apps for healthcare professionals as well as student and patient education.
-
Irish pharma group Nexvet sign R&D pet drug deal
07 July, 2015
Nexvet Biopharma, the listed Irish group developing cutting edge therapies for domestic pets, has signed an R&D deal with Japanese animal health group Zenoaq.
-
Donegal medical plant Randox Teo to create 300 jobs over a five year period
08 July, 2015
The Government has approved an investment by Údarás na Gaeltachta of €5 million research and development grant assistance to be paid over a period of five years to Randox Teo in Dungloe.
-
Economy to grow by 5.3% this year according to Ibec
10 July, 2015
Ibec have today released their latest Quarterly Economic Outlook which calls on Government to seek further flexibility in the EU fiscal rules in order to significantly ramp up investment expenditure in October's budget.
-
Ireland wins a strong share of global investment for the first half of 2015 according to the IDA
13 July, 2015
In a press release issued today, the IDA have claimed that Ireland has won a strong share of global investment for Dublin and regional locations in the first half of 2015, despite intense international competition and economic uncertainty in Europe.
-
GSK to create 50 jobs in Sligo
15 July, 2015
Global healthcare company GSK is recruiting 50 permanent and temporary staff in Sligo this year, the company has announced. The roles will vary across a range of disciplines including engineering, quality, technical, logistics, finance and project management.
-
Malin announces $80m investment in Immunocore
16 July, 2015
Malin has said it will invest $80m in Immunocore as part of a $320m financing round.
-
SMEs report positive growth as economic recovery strengthens
20 July, 2015
The latest ISME Quarterly Business Trends Survey for the second quarter of 2015 shows that there was an increase in 10 of the 12 economic indicators tracked.
-
Global start ups relocate to Cork for IndieBio programme
21 July, 2015
It was announced today that the world’s first and only synthetic biology accelerator programme is again underway in Cork with start-ups from around the world, relocating to Ireland especially for the programme.
-
Dublin based Horizon Pharma raises its offer to purchase Depomed
22 July, 2015
The deal has the potential to almost double Horizon Pharma's portfolio of marketed medicines.
-
Abbott profits beats estimates due to higher than expected sales of generics
23 July, 2015
Abbott Laboratories, which employs almost 3000 people in Ireland, reported a slightly better-than-expected quarterly profit, helped by higher sales of its branded generics.
-
Biopharmaceutical services firm Parexel to create 130 jobs
27 July, 2015
Biopharmaceutical services firm Parexel is to create 130 jobs in Dublin over the next 18 months, the company said today.
-
Irish clinical trials group Icon posts 3.4% rise in revenues
29 July, 2015
Icon which is a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries said income from operations totalled was up 41% year on year.
-
Irish economic recovery continues with 6.5% growth
30 July, 2015
Ireland’s economy grew by more than 6% in the first three months of the year compared with the same period in 2014, new figures reveal.
-
Generic drug manufacturer Amneal to create up to 300 jobs in Tipperary
31 July, 2015
US headquartered Amneal has bought the former Johnson & Johnson factory plan in Cashel Co Tipperary. The 200,000 square foot plant was sold by Johnson & Johnson in 2011 to a Singapore based investment firm.
-
Irish manufactoring sector growth accelerates in July
04 August, 2015
Irish manufacturing sector growth rebounded from a 16-month low in July as the weak euro boosted exports, a survey showed on Tuesday. The Investec Manufacturing Purchasing Managers’ Index rose to 56.7 in July from 54.6 in June.
-
Dublin based Shire bids $30 billion for Baxter spin-off Baxalta
06 August, 2015
Drugmaker Shire is seeking to buy Baxalta, a company spun-off by Baxter International, for $30 billion (€27.35 billion) to forge the leading global specialist in rare diseases.
-
Revenue at Dublin based Jazz Pharmaceuticals increases by 15% in second quarter
07 August, 2015
Dublin-based Jazz Pharmaceuticals said revenues rose 15 per cent in the second quarter of the year as sales of its Xyrem product increased. The company reaffirmed financial guidance for 2015, which puts revenue in the projected range of $1.31 billion to $1.37 billion
-
Dublin based Mallinckrodt buys immunotherapy drug maker Therakos for $1.33bn
11 August, 2015
Dublin-based drugmaker Mallinckrodt said Monday it would buy immunotherapy company Therakos in a deal valued at about $1.33 billion, its second major acquisition this year aimed at strengthening its hospital offerings.
-
Increase of 33% in professional job opportunities
13 August, 2015
There was a 33% increase in the number of professional job opportunities (12,887) when compared with the same month last year (9,699) according to the July 2015 Morgan McKinley Irish Employment Monitor which has been released today.
-
Goodbody Stockbrokers predict that Ireland will be the fastest growing economy in the EU in 2015
14 August, 2015
Goodbody Stockbrokers have today upgraded their economic growth forecasts, and now expect GDP growth of 5.5% in 2015 (previously 4.3%), with 4% expected for both 2016 and 2017.
-
Novartis buys remaining rights to GSK multiple sclerosis compound Ofatumumab
24 August, 2015
Novartis has agreed to buy all remaining rights to Ofatumumab from Britain’s GlaxoSmithKline for up to $1 billion, boosting the Swiss drugmaker’s stable of multiple sclerosis (MS) treatments.
-
Science education programmes accompany new Amgen facility
25 August, 2015
Biotechnology company Amgen, which yesterday unveiled its €260m facility in Dún Laoghaire, has launched two science education courses aimed at reaching more than 53,000 students and hundreds of teachers.
-
Irish medical firm Mainstay receives third US patent
27 August, 2015
Irish medical devices firm Mainstay Medical, which agreed a debt facility of up to $15 million (€13.1 million) earlier this week, has been awarded an additional US patent as it continues with moves to bring a new product to market.
-
Bristol-Myers buys rights to fibrosis drug from private drug maker Promedior
31 August, 2015
Drugmaker Bristol-Myers Squibb said it would buy the worldwide rights to a mid-stage fibrosis drug from privately held Promedior for up to $1.25 billion.
-
Eurozone unemployment falls to three year low in July
01 September, 2015
The European Union's statistics office Eurostat said today that euro zone unemployment was 10.9 percent in July, the first time below 11 percent since February 2012.
-
Novartis brings first "biosimilar" drug to US market
04 September, 2015
The drug, which helps fight infections in cancer patients, is first biotech copycat therapy to win approval from US regulators.
-
Mylan to ask Perrigo shareholders to accept $27.1bn takeover
08 September, 2015
Mylan has said it plans to start its $27.1 billion takeover of Dublin-based Perrigo on Monday next, asking shareholders of the over-the-counter drug maker to accept a proposal that the company’s executives have refused.
-
Bio Pharma Job Seeker Support Programme
18 September, 2015
Are you looking for a future career in Biopharma? Gain and industry recognised qualification with Pharmachem Skillnet and IT Tallaght plus a 3 month temporary contract for successful participants in one of 5 Bio-Pharma companies. For more information please see below.
-
Irish economy set to grow by 6.5% in 2015 in revised forecast
29 September, 2015
The Irish economy is now expected to rise by 6.5 per cent this year and 4 per cent next year, according to a revised forecast issued by Davy.
-
Ireland now ranks as the 8th most competitive country in the Eurozone
02 October, 2015
The latest report from the World Economic Forum (WEF) shows that Ireland now ranks 8th most competitive country in the eurozone.
-
Skillnets are partnering with Ibec and Bank of Ireland in supporting the StartUp Gathering 2015
06 October, 2015
A number of free training and networking events are being held in 5 cities to support start-ups across the country.
-
Irish drugmaker Alkermes wins FDA approval for new Schizophrenia drug
07 October, 2015
Alkermes’s drug, called Aristada, is a long-acting injectable medicine with options to be taken once monthly or every six weeks, the company said in a statement announcing the US Food and Drug Administration’s approval of the drug.
-
GDP in 2015 to grow by 5.9% according to Ibec Quarterly Economic Outlook
12 October, 2015
Ibec also predicts that the economy is set to expand in value terms by an unprecedented €20 billion (11%) during 2015, leading to a rapid improvement in Ireland’s debt and deficit positions.
-
Budget 2016
14 October, 2015
The main points from Budget 2016 speech made by Minister for Finance Michael Noonan - ref Irish Times
-
Regeneron announces 200 jobs in expansion of its Limerick facility
20 October, 2015
BIOPHARMACEUTICAL firm Regeneron has announced the creation of 200 new jobs, as part of a €308m investment in Limerick.
-
Spanish healthcare firm to create 140 Dublin based jobs
22 October, 2015
Spanish healthcare company Grifols is to create 140 jobs in Dublin as part of a $100 million investment. The company, which is a Barcelona-based producer of blood plasma solutions, is opening a new centre for its bioscience division at Grace Castle Business Park in south Dublin. The 22,000 metre site facility, which will house operating activities including the warehousing of plasma, product labelling, and administrative and commercial activities, is expected to come on stream early next year.
-
Pharma Industry Awards 2015
23 October, 2015
The Pharma Industry Awards ceremony took place in the Ballsbridge Hotel, Dublin last night 22nd October. Congratulations and well done to the winners in the various categories.
-
PharmaChem Skillnet JSSP Programme 2015 launched in Athlone
28 October, 2015
The Minister of State at the Department of Social Protection, Kevin Humphreys launched the first of two Pharmachem Skillnet Bio-Pharma programmes yesterday in Athlone, Co Westmeath. The programme was launched in association with IT Tallaght, the Department of Social Protection, IDA Ireland, PharmaChemical Ireland, PPD, Alexion, Genzyme and Hovione.
-
Shire to purchase Dyax for $5.9bn
03 November, 2015
Dublin-based Shire has agreed to buy Dyax Corp for about $5.9 billion to gain access to the drug developer’s late-stage experimental treatment for a dangerous inflammatory disease that can block breathing
-
AstraZeneca to buy US firm ZS Pharma for €2.5bn
09 November, 2015
Drug giant AstraZeneca has agreed to buy US firm ZS Pharma in a $2.7bn (€2.5bn) cash deal. It will give UK-based AstraZeneca access to a drug that could potentially treat life-threatening condition, hyperkalaemia. The drug, ZS-9, is currently under regulatory review by the US Food and Drug Administration.
-
PharmaChem Skillnet Foot in the Door Event 2015
19 November, 2015
Our Annual Foot in the Door event takes place on Monday 23rd November in the Clayton Silversprings Hotel, Tivoli, Cork between 6.00pm and 9pm.
-
Great turnout for PharmaChem Skillnet Foot in the Door 2015
26 November, 2015
The PharmaChem Skillnet hosted its Annual Foot in the Door Event for Jobseekers on Monday 23rd November at the Clayton Silversprings Hotel, Cork. There was great support from Industry with several of the companies in attendance currently recruiting.
-
GE Healthcare to create 140 jobs in Cork
01 December, 2015
GE Healthcare which currently employs close to 500 people has announced plans to double the Carrigtwohill facility's production capacity.
-
Innovation 2020 launched
09 December, 2015
Innovation 2020, Ireland’s 5-year strategy for research and development, science and technology was launched yesterday. The strategy is aimed at building on the Government’s science strategy over the past decade, which has seen Ireland dramatically improve its performance globally in this area.
-
German Medical Device firm Phenox to create 65 jobs in Galway
14 December, 2015
Phenox founder and managing director Hermann Monstadt said the Galway facility will be critical to the company’s global expansion plans and “will produce products specifically for the US and other international markets as well as provide additional support for EU markets”.
-
UK's second largest drug maker AstraZeneca buys 55% stake in Acerta Pharma
17 December, 2015
AstraZeneca will pay $2.5 billion upfront, and another $1.5 billion when Acerta’s experimental drug acalabrutinib is approved by a regulator or at the end of 2018, whichever comes first, according to a statement today, Thursday.